to limit cost-sharing to a copay of no more than $35 and cap costs at no more than $100 per month.

Additionally, the Endocrine Society has partnered with IPEN to raise awareness of health risks associated with endocrine-disrupting chemicals. Experts in the field have developed a guide for public interest organization and policy makers urging them to prioritize specific actions on EDCs, including a coherent identification process linked to control measures to reduce widespread exposures.

In 2023, Delia M. Sosa and other members

1.Previous
3.Next